Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

India

India Articles

Companies

News: Indian drug maker Venus Remedies has received a Good Manufacturing Practice (GMP) certificate from Kenya's Pharmacy & Poisons Board . An assessment carried out by the Inspectorate... 2008-08-20


Companies

US-based Vanguard Pharmaceutical has signed a contract to sell the generics portfolio of India's Arbro Pharmaceutical in Latin America and the Caribbean. The deal gives Vanguard exclusive... 2008-08-04


Industry

The first half of 2008 has brought mixed results for pharmaceutical companies operating in Romania. Often considered as a high potential market for investment, it appears that the... 2008-07-31


Industry

Ranbaxy Pharmaceuticals has announced that it has launched a generic 40 mg version of ulcer drug Prilosec (omeprazole) in the US under an agreement with AstraZeneca . The drug... 2008-07-30


Companies

Following the rejection of its merger agreement with Israel-based drug manufacturer Taro Pharma , India's Sun Pharma has launched a hostile takeover bid.

2008-07-15

Industry

In an effort to penetrate emerging markets, UK specialty drugmaker Sinclair Pharma has contracted Mumbai-based Wockhardt to distribute four of its products in India. The deal runs... 2008-06-30


Companies

India's Plethico Pharmaceuticals is targeting acquisitions in the US and Brazil in order to expand its Americas over-the-counter (OTC) and nutraceuticals businesses, according to... 2008-06-20


Companies

US-based Mylan has signed an agreement with India's NATCO Pharma to market a generic version of Israeli drugmaker Teva's multiple sclerosis drug Copaxone (glatiramer) in the US, Europe,... 2008-06-12


Industry

In an effort to diversify and increase its presence in emerging markets, Japanese drugmaker Daiichi Sankyo has purchased a controlling stake in Indian generics firm Ranbaxy Laboratories.... 2008-06-12


Companies

Indian generics firm Zydus Cadila has announced that it is to acquire 70% of South Africa's Simayla Pharmaceuticals, as part of its drive to penetrate southern Africa's generics markets.... 2008-06-10

1 to 10 of 113 results
<< | < | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | > | >>
Insight